Avidity Biosciences, Inc. (RNA) Reports Q3 Loss, Lags Revenue Estimates

Avidity Biosciences, Inc. (RNA) came out with a quarterly loss of $0.65 per share versus the Zacks Consensus Estimate of a loss of $0.79. This compares to loss of $0.71 per share a year ago. These figures are adjusted for non-recurring items.This quarterly report represents an earnings surprise of 17.72%. A quarter ago, it was expected that this company would post a loss of $0.76 per share when it actually produced a loss of $0.65, delivering a surprise of 14.47%.Over the last four quarters, the company has ...